Integra LifeSciences Holdings Corp diskutieren
Integra LifeSciences Holdings Corp
WKN: 897013 / Symbol: IART / Name: Integra / Aktie / Ausrüstung & Versorgung / Mid Cap /
18,30 €
-2,66 %
Integra LifeSciences Holdings Co. (NASDAQ: IART) was downgraded by analysts at Citigroup Inc. from a "neutral" rating to a "sell" rating.
Ratings data for IART provided by MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ: IART) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating. They now have a $43.00 price target on the stock, down previously from $56.00.
Ratings data for IART provided by MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ: IART) had its price target lowered by analysts at Morgan Stanley from $44.00 to $37.00. They now have an "underweight" rating on the stock.
Ratings data for IART provided by MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ: IART) is now covered by analysts at CL King. They set a "buy" rating and a $50.00 price target on the stock.
Ratings data for IART provided by MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ: IART) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $49.00 price target on the stock, up previously from $40.00.
Ratings data for IART provided by MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ: IART) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for IART provided by MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ: IART) had its price target lowered by analysts at Bank of America Co. from $42.00 to $26.00. They now have an "underperform" rating on the stock.
Ratings data for IART provided by MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ: IART) had its price target lowered by analysts at Morgan Stanley from $37.00 to $24.00. They now have an "underweight" rating on the stock.
Ratings data for IART provided by MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ: IART) had its price target raised by analysts at Morgan Stanley from $24.00 to $27.00. They now have an "underweight" rating on the stock.
Ratings data for IART provided by MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ: IART) had its price target lowered by analysts at Citigroup Inc. from $23.00 to $20.00. They now have a "sell" rating on the stock.
Ratings data for IART provided by MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ: IART) had its price target lowered by analysts at BTIG Research from $22.00 to $20.00. They now have a "sell" rating on the stock.
Ratings data for IART provided by MarketBeat
Neueste Beiträge
Tigress_Financial in Apple Inc. diskutieren